Furosemide Injection, Solution
Product Images NDC 55154-2365

4 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 55154-2365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

31fcf3f2 C614 4ca0 A685 07337b824a91 00

31fcf3f2 C614 4ca0 A685 07337b824a91 00
Label for Furosemide Injection USP 40 mg per 4 mL (10 mg/mL) by Cardinal Health, containing 5 single-use vials of 4 mL each. The label includes usage instructions for intravenous or intramuscular administration, storage conditions, and safety warnings. It specifies that the product is sterile, nonpyrogenic, and RX only, distributed by Hospira, Inc. and Cardinal Health.*
FDA Label Image

Hospira Logo (Furosemide 01)

FDA Label Image

Structural Formula Furosemide (Furosemide 02)

Structural Formula Furosemide (Furosemide 02)
Chemical structure diagram of the active ingredient Furosemide, showing its molecular components including a chlorinated benzene ring, sulfonamide group, and a furan ring.*
FDA Label Image

Hospira Logo (Furosemide 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.